Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

1 projects found matching your search criteria :

  1. New opportunities for use of PERK kinase inhibitors in eIF2alfa factor-dependant signalling pathway in antitumor therapy

    Call: PRELUDIUM 10 , Panel: NZ3

    Principal investigator: dr Wioletta Rozpędek-Kamińska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski